tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND
US Market
LGND
Ligand Pharma
RESEARCH TOOLSreports

Ligand Pharma (LGND) Income Statement

834 Followers

Ligand Pharma Income Statement

Last quarter (Q4 2025), Ligand Pharma's total revenue was $59.67M, an increase of 39.37% from the same quarter last year. In Q4, Ligand Pharma's net income was $44.78M. See Ligand Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 268.09M$ 167.13M$ 131.31M$ 196.25M$ 241.54M
Gross Profit
$ 261.50M$ 156.06M$ 96.27M$ 143.42M$ 179.37M
Operating Expenses
$ 214.30M$ 178.66M$ 84.32M$ 140.38M$ 75.52M
Depreciation and Amortization
$ 33.77M$ 35.24M$ 36.52M$ 43.39M$ 50.95M
EBITDA
$ 192.74M$ 40.79M$ 100.84M$ 81.20M$ 142.77M
Operating Income
$ 47.20M$ -22.61M$ 11.94M$ 3.04M$ 103.85M
Other Income/Expenses
$ 111.76M$ 25.12M$ 51.72M$ 32.97M$ -31.65M
Pretax Income
$ 158.96M$ 2.52M$ 63.66M$ 36.01M$ 72.20M
Net Income
$ 124.45M$ -4.03M$ 52.15M$ -33.36M$ 57.14M
Per Share Metrics
Basic EPS
$ 6.44$ -0.22$ 3.02$ -1.98$ 3.46
Diluted EPS
$ 6.13$ -0.22$ 2.94$ -1.98$ 3.34
Weighted Average Shares Outstanding
 19.34M 18.29M 17.30M 16.87M 16.63M
Weighted Average Shares Outstanding (Diluted)
 20.29M 18.29M 17.76M 16.87M 17.25M
Currency in USD

Ligand Pharma Earnings and Revenue History